18 LONG TERM CARE TODAY Fall/Winter 2026 A s with any instrument in the medical field, artificial intelligence (AI) can be a life-changing tool in the right hands. Recently, that potential was demonstrated during a wound care evaluation involving peopleCare Communities, the Ontario Bioscience Innovation Organization (OBIO) and Skinopathy. Skinopathy, an Ontario-based health technology company, has developed an AI-driven platform to support skin and wound assessment, treatment planning, and clinical documentation. Using an app on a mobile device, nurses photograph a wound and upload the image to the platform. It then measures and analyzes the wound, identifies tissue types, recommends evidence-based treatment options, documents the assessment, and tracks healing over time – all while leaving the final clinical decision to the care team. "We call it ‘glass box’ technology in that it tells you exactly what we see, and why it leads to a decision,” says Keith Loo, Skinopathy’s CEO and Co-Founder. “Think of it as an advanced stethoscope or just another tool in your tool belt. We're not trying to replace your judgment; we're just trying to show you objective facts and what that can lead to." Discovering Skinopathy Skinopathy Wounds was originally developed to help clinicians and patients detect skin cancer using affordable, AI-powered technology. As its capabilities and reputation grew, burn units and emergency responders began using the same technology to gauge the severity of burns. It wasn't long before the long-term care sector took notice. Jenn Killing, Vice President of Quality, Research and Strategic Partnerships at peopleCare Communities, first crossed paths with Loo and his team at a health care innovation showcase and quickly recognized Skinopathy’s potential in a long-term care environment. "When I saw the demonstration, I realized this type of technology could be game-changing for our nurses,” she says. “It could provide better guidance, help us track progress, support care planning, and allow us to connect with specialists digitally, which is one of the biggest challenges we face in long-term care." As residents become older and more medically complex, consistent skin and wound assessments have become increasingly difficult. Variations between care team Applying AI to wound care Inside peopleCare's Skinopathy Wounds evaluation members, lighting conditions and assessment times can all affect the accuracy and consistency of assessments, and these inconsistencies can hinder timely and effective responses. Recognizing the potential for addressing these issues, Killing and her team at peopleCare partnered with Skinopathy for a year-long initiative to explore whether its AI product could help clinicians deliver faster, more consistent wound assessments while reducing documentation burdens. Funding for the project was provided through a partnership with OBIO’s Life Sciences Critical Technologies & Commercialization Centre of Excellence, an organization that connects health technology innovators with health care providers to evaluate and scale promising new solutions. "In a resource-strapped sector such as long- term care, this type of funding for innovation is invaluable,” Killing says. Bringing Skinopathy home peopleCare began evaluating the AI tech in November 2024 with Mazhar Muhammed, an experienced registered nurse with the organization, as its clinical lead. Over the next 12 months, Muhammed conducted wound assessments using both Skinopathy Wounds and peopleCare's existing skin and wound care platform, comparing results along the way and collecting feedback to help Loo and his team refine the platform for use in a long-term care environment. Initially, Muhammed recalls, there was some hesitation because skin and wound care process and documentation is subject to rigorous Ministry of Long-Term Care requirements. Those concerns eased as the platform WOUND CARE
View this content as a flipbook by clicking here.